A composition, method, and application for simultaneous detection of Staphylococcus aureus and Salmonella based on CRISPR-Cas12a / Cas12b.
By using RPA-CRISPR-Cas12a/Cas12b technology, combined with carefully designed crRNA and sgRNA, and optimizing the reaction system, the problems of cross-interference and stability in the detection of Staphylococcus aureus and Salmonella have been solved, achieving rapid and accurate dual detection, which is suitable for food safety testing.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NANJING FOOD & DRUG SUPERVISION & INSPECTION INST
- Filing Date
- 2026-04-22
- Publication Date
- 2026-07-17
AI Technical Summary
Existing technologies suffer from cross-interference and low stability when detecting Staphylococcus aureus and Salmonella. Furthermore, traditional methods are highly dependent on equipment and involve cumbersome procedures, making it difficult to achieve rapid and accurate multiplex detection.
Using RPA-CRISPR-Cas12a/Cas12b technology, and through carefully designed highly specific crRNA and sgRNA combined with thiomodified probes, we can achieve simultaneous detection of Staphylococcus aureus and Salmonella. We have optimized the reaction system and parameters to improve the specificity and sensitivity of the method.
It enables rapid and accurate detection of Staphylococcus aureus and Salmonella within 1 hour, with good specificity and high sensitivity. It is suitable for food safety testing in different scenarios and avoids equipment dependence and cumbersome operation.
Smart Images

Figure CN122081529B_ABST